← Back to Intel
Insider ActivityDRUG
Cormorant Asset Management, LP, Insider at BRIGHT MINDS BIOSCIENCES INC., sold $9.8M of DRUG
Updated Jun 14, 2026
Cormorant Asset Management, LP
Insider
BRIGHT MINDS BIOSCIENCES INC. ·
$DRUG
Transaction Details
| Insider | Cormorant Asset Management, LP |
|---|---|
| Title | Insider |
| Company | BRIGHT MINDS BIOSCIENCES INC. |
| Ticker | DRUG |
| Transaction Type | Sale |
| Transaction Date | 2026-04-28 |
| Shares Traded | 109,331 |
| Price Per Share | $89.5 |
| Total Value | $9.8M |
| Filed Date | 2026-04-30 |
| Accession Number | 0000929638-26-001708 |
Ownership Context
| Shares Owned After Transaction | 950,000 |
|---|---|
| Ownership Type | Indirect |
SEC Filing
Accession: 0000929638-26-001708
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for DRUG — BRIGHT MINDS BIOSCIENCES INC. →
Track DRUG insider activity in real time on The Wire →
Get alerts when Cormorant Asset Management, LP files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:15 UTC